Neurogene share price logo

Neurogene

NASDAQ: NGNE

Small Cap

$35.67

-1.01

(-2.75%)

as on

Neurogene Stock Performance

as on August 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $35.33
    $36.97
    downward going graph

    0.95%

    Downside

    3.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $15.93
    $43.66
    downward going graph

    55.34%

    Downside

    22.40%

    Upside

    downward going graph

Neurogene share price movements today

Previous Close
$36.68
Open
$36.97
Volume
185.5K
Market Cap
$723.2M
Day's Low - High
$35.33 - $36.97
52 Week Low - High
$15.93 - $43.66

Neurogene Historical Returns

1 Month Return
-3.14 %
3 Month Return
+ 21.19 %
1 Year Return
+ 76.21 %
3 Year Return
0 %
5 Year Return
0 %

Neurogene Stock Fundamentals & Key Indicators

Check Neurogene market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$723.2M

EPS (TTM)

-5.51

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.47

Industry PE ratio

-7.283372093023256

PEG Ratio

0.36731366192092846

EBITDA

-106.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-45.11%

Neurogene Stock Valuation

Track how Neurogene P/E has moved over time to understand its valuation trends.

Neurogene in the last 5 years

  • Overview

  • Trends

Lowest (-105.03x)

December 31, 2021

Industry (-7.28x)

December 31, 2025

Today (-4.86x)

December 31, 2025

Highest (-2.37x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -4.86x

Neurogene vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neurogene with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$723.2MNA-6.470.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Neurogene Stock including INR - Dollar returns

The Neurogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Neurogene investment value today

Current value as on today

₹1,91,239

Returns

₹91,239

(+91.24%)

Returns from Neurogene Stock

₹73,915 (+73.92%)

Dollar Impact

₹17,324 (+17.32%)

Analyst Recommendation on Neurogene Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Neurogene. Average target price of $80.43

Neurogene Share Price Target

Get share price movements and forecasts by analysts on Neurogene.

What analysts predicted

55.65%UPSIDE

Target Price

$80.43

Current Price

$35.67

Analyzed by

9 Analysts

Target

$80.43

Neurogene target price $80.43, a slight upside of 55.65% compared to current price of $35.67. According to 9 analysts rating.

Indian Investors' Interest in Neurogene Stock

Search interest for Neurogene Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-48% versus previous 30 day period

Neurogene Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
-
-
-
-
-
-
-
-
Gross Profit
0
0
-16
-15
-17
-19
-17
0
0
-
Operating Income
-18
-20
-22
-21
-25
-26
-23
-27
-33
-36
EBITDA
-16
-17
-19
-18
-21
-21
-20
-23
-30
-32
Interest Expense
0
0
0
0
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
2
Income Before Tax
-16
-18
-20
-19
-22
-22
-20
-24
-30
-34
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-18
-20
-19
-22
-22
-20
-24
-30
-34
Net Profit Margin
0.00%
11.68%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Neurogene Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
25
-
-
-
-
-
0
-
Gross Profit
-
25
0
-1
-42
-3
-3
-2
-3
Operating Income
-51
-23
-24
-41
-50
-56
-55
-82
-103
EBITDA
-50
-31
-69
-31
-49
-51
-33
-71
-87
Interest Expense
-
-
0
-
-
0
0
0
0
Depreciation
-
-
0
1
0
3
3
3
3
Income Before Tax
-50
-31
-69
-33
-50
-55
-36
-75
-90
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-50
-31
-69
-33
-50
-55
-36
-75
-90
Net Profit Margin
0.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-251.03%
0.00%

Neurogene Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-18
-20
-19
-22
-22
-20
-24
-30
-34
Operating Cash Flow
-21
-15
-15
-17
-20
-19
-19
-16
-26
-23
Investing Cash Flow
29
-23
-28
-102
-45
7
22
29
46
6
Financing Cash Flow
-6
0
0
190
0
0
9
20
0
5
Change in Cash
1
-39
-44
69
-65
-11
12
32
20
-11

Neurogene Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-31
-8
-33
-50
-55
-36
-75
-90
Operating Cash Flow
-44
-31
-15
-24
-46
-52
-51
-70
-77
Investing Cash Flow
64
55
0
-2
-18
-2
25
-125
14
Financing Cash Flow
0
0
82
77
51
66
92
184
30
Change in Cash
19
24
66
49
-13
11
66
-11
-32

Mutual Funds that own Neurogene Stock

Check out the Mutual Funds with significant holdings in Neurogene.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.522835%
502723
Fidelity Advisor Series VII
1.222969%
243700
Fidelity Salem Street Trust
0.639723%
127477
Fidelity Concord Street Trust
0.543476%
108298
Meridian Fund Inc
0.380686%
75859

Global Institutional Holdings in Neurogene

Funds
Holdings
Felix Baker
4.98%
Vanguard
3.2%
iShares
2.92%
Xtrackers
1.03%
Fidelity
0.5%

Insights on Neurogene

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NGNE stock has moved up by 91.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NGNE has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 410.1%

About Neurogene

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
OrganisationNeurogene
Headquarters535 W 24th Street, New York, NY, United States, 10011
IndustryBiotechnology
CEODr. Rachel L. McMinn Ph.D.
E-voting on sharesClick here to vote

Key Management of Neurogene

Name

Title

Ms. Christine Mikail Cvijic J.D.

President, CFO & Director

Ms. Donna M. Cochener-Metcalfe J.D., L.L.M.

Senior VP, General Counsel & Corporate Secretary

Ms. Christina Shafer

Chief Commercial Officer

Dr. Rachel L. McMinn Ph.D.

Founder, Executive Chair & CEO

Dr. Julie Jordan M.D.

Chief Medical Officer

Dr. Stuart Cobb Ph.D.

Chief Scientific Officer

Ms. Lina Li

Executive Director of Investor Relations

Dr. Andrew E. Mulberg CPI, FAAP, M.D.

Senior VP of Regulatory Affairs, Quality Assurance & Quality Control

Mr. Ricardo Jimenez

Senior Vice President of Technical Operations

Mr. Arvind Sreedharan

Senior Vice President of Business Operations

FAQs

What is Neurogene share price today?

Neurogene share price today is $35.67 as on at the close of the market. Neurogene share today touched a day high of $36.97 and a low of $35.33.

What is the 52 week high and 52 week low for Neurogene share?

Neurogene share touched a 52 week high of $43.66 on and a 52 week low of $15.93 on . Neurogene stock price today i.e. is closed at $35.67,which is 18.30% down from its 52 week high and 123.92% up from its 52 week low.

What is Neurogene's market capitalisation today?

Neurogene market capitalisation is $0.00T as on .

How to invest in Neurogene Stock (NGNE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neurogene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurogene Shares that will get you 0.0421 shares as per Neurogene share price of $35.67 per share as on August 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Neurogene Stock (NGNE) from India?

Indian investors can start investing in Neurogene (NGNE) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Neurogene stock (as per the Rupee-Dollar exchange rate as on ). Based on Neurogene share’s latest price of $35.67 as on August 19, 2026 at 8:46 am IST, you will get 0.2803 shares of Neurogene. Learn more about fractional shares .